Drugs / citrate
Trials 8 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT03114722 | Jul 2017 → Jul 2018 | vascular occlusion disorder | National University Hospital, Singapore | Unknown | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT05814341 | Jul 2023 → Dec 2024 | — | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| Phase 45 trials | ||||||
| Phase 4 | NCT06807905 | Feb 2019 → Sep 2020 | end stage renal failure | University Medical Centre Ljubljana | Completed | No outcome recorded |
| Phase 4 | NCT03035812 | Feb 2017 → Feb 2020 | metabolic acidosis, nephrolithiasis | Jean-Philippe Bertocchio | Completed | No outcome recorded |
| Phase 4 | NCT02669589 | Mar 2016 → Apr 2019 | acute kidney injury | University Hospital Muenster | Completed | No outcome recorded |
| Phase 4 | NCT02860299 | Feb 2015 → Jan 2016 | acute kidney injury | Centre Hospitalier Universitaire Dijon | Completed | No outcome recorded |
| Phase 4 | NCT00294502 | Sep 2003 → May 2004 | end stage renal failure | Henry Ford Health System | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02194569 | Jul 2014 → Jun 2017 | acute kidney injury | Ziekenhuis Oost-Limburg | Completed | No outcome recorded |
Also used as a comparator or background therapy in 4 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT01483872 Comparator | Mar 2012 → Sep 2013 | — | University of California, San Diego | Terminated | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT02868697 Background | Nov 2013 → Aug 2015 | — | Hamad Medical Corporation | Completed | No outcome recorded |
| Phase 4 | NCT00286273 Comparator | Mar 2003 → Jan 2008 | acute kidney injury | Onze Lieve Vrouwe Gasthuis | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07366372 Background | May 2023 → Nov 2024 | — | Tanta University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 12 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | citrate | “Oral alkalization with sodium bicarbonate (NaHCO3 ) or citrate is prescribed for conditions ranging from metabolic acidosis to nephrolithiasis.” PMID 34564842 ↗ Oct 202111“taurolidine citrate, 4% citrate /25000 IU unit urokinase (TauroLock U25000” NCT02868697 ↗ |
| Known as | Dirinco Citra-Lock 4% | “use of 4% citrate lock (Dirinco Citra-Lock 4%)” NCT03114722 ↗ |
| Action | Inhibit | “Citrate chelates ionised calcium in blood, inhibiting calcium-dependent clotting pathways.” NCT03114722 ↗ |
| Route | Other | “a Heparin or Citrate Lock is Injected” NCT02860299 ↗ |